Prelude Therapeutics Incorporated
Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
Last updated:
Abstract:
The disclosure is directed to methods of treatment using compounds of Formula (I). ##STR00001##
Status:
Application
Type:
Utility
Filling date:
3 Apr 2020
Issue date:
19 May 2022